8/20/24 17:06 | 8/16/24 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Kelly James Patrick | | O | EVP,CFO, | M.d | 31 | 12.96 | 0 | 2 | 20 | 14 | D | | | | | | | | | | | | | | |
3/12/24 20:46 | 3/10/24 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Kelly James Patrick | MD | O | EVP,CFO, | M.d | 0 | 0.00 | 0 | 5 | 53 | 13 | D | | | | | | | | | | | | | | |
3/11/24 21:39 | 3/7/24 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Kelly James Patrick | MD | O | EVP,CFO, | M.d | 0 | 0.00 | 0 | 12 | | 11 | D | | | | | | | | | | | | | | |
8/18/23 16:37 | 8/16/23 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Kelly James Patrick | MD | O | EVP,CFO, | M.d | 0 | 0.00 | 0 | 2 | 107 | 5 | D | | | | | | | | | | | | | | |
3/14/23 17:19 | 3/10/23 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Kelly James Patrick | MD | O | EVP,CFO, | M.d | 30 | 6.52 | 0 | 5 | | 3 | D | | | | | | | | | | | | | | |
8/18/22 17:02 | 8/16/22 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Kelly James Patrick | MD | O | EVP,CFO, | M.d | 0 | 0.00 | 0 | 2 | | 1 | D | | | | | | | | | | | | | | |
3/4/20 17:01 | 3/2/20 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kelly James Patrick | DC | O | EVP,CFO | S.m | -195 | 10.36 | 0 | -19 | -9 | 187 | D | | | | | | | | | | | | | | |
1/6/20 17:25 | 1/2/20 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kelly James Patrick | DC | O | EVP,CFO | S | -64 | 15.94 | 0 | -4 | -2 | 206 | D | | | | | | | | | | | | | | |
3/4/19 17:06 | 3/1/19 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kelly James Patrick | DC | O | EVP,CFO | S.m | -274 | 19.98 | 0 | -14 | -6 | 210 | D | | | | | | | | | | | | | | |
1/4/19 16:33 | 1/2/19 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kelly James Patrick | DC | O | EVP,CFO | S.m | -160 | 26.37 | 0 | -6 | -3 | 193 | D | | | | | | | | | | | | | | |
3/2/18 17:34 | 3/1/18 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kelly James Patrick | DC | O | EVP,CFO | S.d | -160 | 18.72 | 0 | -9 | -4 | 200 | D | | | | | | | | | | | | | | |
1/4/18 17:12 | 1/2/18 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kelly James Patrick | DC | O | EVP,CFO | M.d | 0 | 0.00 | 0 | 18 | 12 | 168 | D | | | | | | | | | | | | | | |
1/4/18 17:12 | 1/2/18 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kelly James Patrick | DC | O | EVP,CFO | S.d | -140 | 15.35 | 0 | -9 | -5 | 168 | D | | | | | | | | | | | | | | |
1/5/17 17:01 | 1/3/17 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kelly James Patrick | DC | O | SVP,CFO, | M.d | 0 | 0.00 | 8 | 20 | 40 | 70 | D | 11 | 76 | 37 | -2 | -7 | -1 | 4 | -1 | -3 | -11 | -13 | -15 | | |
1/5/17 17:01 | 1/3/17 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kelly James Patrick | DC | O | SVP,CFO, | S.d | -169 | 15.51 | 8 | -11 | -14 | 70 | D | 11 | 76 | 37 | -2 | -7 | -1 | 4 | -1 | -3 | -11 | -13 | -15 | | |
1/6/16 19:09 | 1/4/16 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kelly James Patrick | DC | O | SVP,CFO, | M.d | 0 | 0.00 | 8 | 17 | 39 | 61 | D | -28 | -37 | -27 | -25 | -6 | 5 | -6 | -6 | -4 | 4 | 1 | -1 | 33 | 80 |
1/6/16 19:09 | 1/4/16 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kelly James Patrick | DC | O | SVP,CFO, | S.d | -86 | 8.96 | 8 | -10 | -14 | 61 | D | -28 | -37 | -27 | -25 | -6 | 5 | -6 | -6 | -4 | 4 | 1 | -1 | 33 | 80 |
3/12/15 18:53 | 3/10/15 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kelly James Patrick | DC | O | SVP,CFO, | M.d | 0 | 0.00 | 11 | 25 | 85 | 53 | D | 187 | -30 | -16 | -12 | -7 | -6 | -3 | 1 | 0 | -6 | -8 | 24 | 19 | -26 |
3/12/15 18:53 | 3/10/15 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kelly James Patrick | DC | O | SVP,CFO, | S.d | -131 | 10.53 | 11 | -12 | -19 | 53 | D | 187 | -30 | -16 | -12 | -7 | -6 | -3 | 1 | 0 | -6 | -8 | 24 | 19 | -26 |
2/20/14 16:39 | 2/18/14 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kelly James Patrick | DC | O | SVP,CFO, | M.d | 0 | 0.00 | 19 | 20 | 90 | 41 | D | 186 | 237 | 23 | -8 | 10 | 10 | 18 | 0 | 2 | 10 | 32 | -30 | -7 | -18 |
11/21/13 20:00 | 11/19/13 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kelly James Patrick | DC | O | SVP,CFO, | S | -40 | 12.07 | 33 | -3 | -10 | 29 | D | 120 | 254 | 63 | 6 | 15 | 62 | 71 | -20 | -8 | -5 | -8 | 23 | -13 | 0 |
7/31/13 16:32 | 7/29/13 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kelly James Patrick | DC | O | SVP,CFO, | M.d | 0 | 0.00 | 9 | 9 | 41 | 32 | D | 64 | 180 | 166 | 139 | 6 | 33 | 29 | 41 | 3 | -5 | -1 | -30 | 5 | 26 |
2/19/13 20:38 | 2/14/13 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kelly James Patrick | DC | O | SVP,CFO, | M.d | 0 | 0.00 | 1 | 17 | 307 | 23 | D | -47 | -17 | -2 | 26 | 5 | -8 | 0 | 0 | -2 | -5 | -3 | 65 | 164 | 241 |
2/21/12 18:00 | 2/16/12 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kelly James Patrick | MD | O | SVP,CFO, | M.d | 0 | 0.00 | 1 | 13 | 999% | 13 | D | -56 | -35 | -13 | -11 | 3 | -4 | -11 | -2 | 0 | 4 | 7 | -12 | -10 | -14 |
2/21/12 18:00 | 2/16/12 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kelly James Patrick | MD | O | SVP,CFO, | S.d | -23 | 4.67 | 1 | -5 | -28 | 13 | D | -56 | -35 | -13 | -11 | 3 | -4 | -11 | -2 | 0 | 4 | 7 | -12 | -10 | -14 |
8/30/11 16:31 | 8/29/11 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kelly James Patrick | MD | O | SVP,CFO, | P | 30 | 5.99 | 1 | 5 | New | 5 | D | -57 | -5 | -19 | -20 | -16 | 0 | 11 | 12 | 0 | -7 | -16 | -21 | -24 | -27 |